Tan, Jing <br/><br/>
Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction.  [electronic resource] 

 -  Heart and vessels  Sep 2009 
 - 329-34 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1615-2573 
<br/><br/><label>Standard No.: </label>10.1007/s00380-008-1128-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers--blood<br/>CD40 Ligand--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Inflammation Mediators--blood<br/>Interleukin-6--blood<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Male<br/>Matrix Metalloproteinase 9--blood<br/>Middle Aged<br/>Myocardial Infarction--immunology<br/>Patient Admission<br/>Predictive Value of Tests<br/>Prospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Tissue Inhibitor of Metalloproteinase-1--blood<br/>Treatment Outcome<br/>Up-Regulation